Lv79
3610 积分 2022-06-20 加入
Aficamten reduces symptoms in obstructive hypertrophic cardiomyopathy. Aficamten reduces symptoms in obstructive hypertrophic cardiomyopathy
26天前
已完结
Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
29天前
已完结
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
1个月前
已完结
Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: Results of a naturalistic study with 3 months follow-up
1个月前
已完结
The Benzodiazepine Withdrawal Symptom Questionnaire
1个月前
已完结
Comparison of efficacy and safety of dual orexin receptor antagonists lemborexant and daridorexant for the treatment of insomnia: a systematic review and meta-analysis
1个月前
已完结
Multiple-dose clinical pharmacology of the selective orexin-1 receptor antagonist ACT-539313
2个月前
已完结
Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers
2个月前
已完结
Intravenous tissue plasminogen activator in acute branch atheromatous disease: Does it prevent early neurological deterioration?
2个月前
已完结
Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke
8个月前
已完结
皖公网安备34019202002308
